No new positives this week

Slides:



Advertisements
Similar presentations
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.
Advertisements

1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.
1 |1 | Countries using and planning to introduce IPV.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
Vaccine in National Immunization Programme Update March 2015.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
World Health Organization
1 |1 | Countries using and planning to introduce IPV.
TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.
World Health Organization
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
1 |1 | Countries using and planning to introduce IPV.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.
NVAC W. R. Dowdle. Laboratory Containment of Wild Poliovirus in the United States Phase I National Survey and Inventory Final Report January.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.
Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.
Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.
Vaccine in National Immunization Programme Update April 2016.
World Health Organization
Data quality for polio eradication: Accuracy & reliability
Perspective and Update
SAGE 2010 Sampling Distribution
Global Polio Eradication: Current Status, Challenges and Future Directions Steven Wassilak, MD Centers for Disease Control and Prevention, Atlanta APHA.
financial requirements
Measles disease An acute viral infection spread via respiratory secretions or aerosols Classic manifestations: Maculopapular rash Fever +cough + coryza/conjuctivities.
reporting rate of discarded cases* per 100'000 population**
Performance of AFP surveillance, 2014
Ageing Matters Somnath Chatterji Information, Evidence and Research
World Health Organization
Monthly Distribution of Wild Poliovirus Cases1,
SAGE 2009 Sampling Distribution
06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Circulating Vaccine-derived Poliovirus*, last 6 months
Sampling Distribution
15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
Monthly Distribution of Wild Poliovirus Cases1,
(70 countries or 36%) (23 countries or 12%)
Countries with Genotype data available
Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.
World Health Organization
24/02/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
World Health Organization
Onset of most recent WPV1 Case Number of WPV infected districts
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries having introduced HepB vaccine
05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Most-affected regions in the Russian Federation
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Mapping Levels of Palliative Care Development: A Global Update
Countries Using Mening Vaccine in National Immunization Schedule 2011
- Use same categories as for bar chart below Introduced Without GAVI
Onset of most recent case Number of infected districts
04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Circulating Vaccine-derived Poliovirus1,
27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
World Health Organization
Presentation transcript:

No new positives this week 05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week No new positives this week The boundaries and names shown and the designations used in the maps in this document do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO 2018. All rights reserved Data in WHO HQ as of 20 Feb. 2018 Data in WHO HQ as of 30 Nov 2010

Global Wild Poliovirus & cVDPV Cases1, Previous 12 Months2 05/04/2019 Global Wild Poliovirus & cVDPV Cases1, Previous 12 Months2 Wild poliovirus type 1 cVDPV type 2 Endemic country 1Excludes viruses detected from environmental surveillance 2Onset of paralysis 21 February 2017 – 20 February 2018 Data in WHO HQ as of 20 Feb. 2018 Data in WHO HQ as of 30 Nov 2010

Global Wild Poliovirus & cVDPV Cases1, Previous 6 Months2 05/04/2019 Global Wild Poliovirus & cVDPV Cases1, Previous 6 Months2 Wild poliovirus type 1 cVDPV type 2 Endemic country 2Current rolling 6 months: 21 August 2017 – 20 February 2018 3Same period previous year: data reported from 21 August 2016 1Excludes viruses detected from environmental surveillance 2Onset of paralysis 21 August 2017 – 20 February 2018 Data in WHO HQ as of 20 Feb. 2018 Data in WHO HQ as of 30 Nov 2010

Global Wild Poliovirus 2013 - 2018 05/04/2019 Global Wild Poliovirus 2013 - 2018 Data in WHO HQ as of 20 Feb. 2018 Data in WHO HQ as of 30 Nov 2010

Global Circulating Vaccine-derived Poliovirus1,2,3 05/04/2019 1For cVDPV definition see http://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf. Niger 2006, Niger 2009, Niger 2010, Chad 2010 cVDPVs are linked to the Nigeria outbreak. Kenya 2012 cVDPVs are linked to the Somalia outbreak. Nigeria figures include cases with WPV1/cVDPV2 mixture: 2005 - 2, 2006 - 1, 2007 - 1, 2008 - 3, 2009 - 1, 2011 - 1; WPV3/cVPDV2 mixture: 2007 - 2. 2 include a cVDPV2 from a contact of a WPV1 case in Nigeria. 3Figures include multiple emergences. 4 stool collected in Sep - 2016 but the final result was reported in 2017. 5 Include contact, healthy and community samples . Positive contact of a negative index AFP case double counted in both AFP cases and other sources count . Data in WHO HQ as of 20 Feb. 2018 Data in WHO HQ as of 30 Nov 2010

Global Surveillance Indicators: Year to Date Comparison 2017 & 2018: 01 January to 20 February 2018* 05/04/2019 *Data for 2017 as of 21 February 2017 and for 2018 as of 20 February 2018 For data at country, regional and global levels from 2000 onwards, see the WHO website at https://extranet.who.int/polis/public/CaseCount.aspx Data in WHO HQ as of 30 Nov 2010